XML 64 R47.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Financial expenses, net (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Schedule of Financial Expenses |
|  | Year ended December, 31 |
|  | 2023 |  |  | 2022 |  |  | 2021 |
|  | (U.S. $ in millions) |
Interest expenses and other bank charges |  | $ | 1,029 |  |  | $ | 930 |  |  | $ | 891 |
(Income) loss from investments (1) |  |  | (68 | ) |  |  | (10 | ) |  |  | 90 |
Foreign exchange (gains) losses, net |  |  | 30 |  |  |  | (16 | ) |  |  | 7 |
Other, net (2) |  |  | 66 |  |  |  | 61 |  |  |  | 71 |
Total finance expense, net |  | $ | 1,057 |  |  | $ | 966 |  |  | $ | 1,058 |
(1) | Loss from investments in 2021 comprised mainly of revaluation gains and loss of Teva’s investment in American Well Corporation (“American Well”).
(2) | Amortization of issuance costs and terminated derivative instruments.

X
- Definition Financial Expenses Net Table [Text Block] + References No definition available. + Details
Name: | teva_FinancialExpensesNetTableTextBlock
Namespace Prefix: | teva_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration